JESSICA GEORGE: Open Payments
NPI 1194133983 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 21 payments from 14 companies in 2025. Trend: 2023 $1,205 · 2024 $1,081 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Janssen Biotech, Inc. | 2 | $64 |
| PFIZER INC. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| ABBVIE INC. | 2 | $35 |
| PharmaEssentia USA Corporation | 1 | $31 |
| Syndax Pharmaceuticals, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| ARRAY BIOPHARMA INC | 1 | $23 |
| Incyte Corporation | 1 | $22 |
Products named: KISQALI, EPKINLY, TALVEY, SCEMBLIX, LUTATHERA, BESREMI, TECVAYLI, INLYTA.
Industry payments across VA — which companies pay providers there.
